Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Increased Incidence of Viral Reactivation after T Cell Replete Haploidentical Stem Cell Transplantation in Association with Delayed Immune Reconstitution

Ioannis Tsonis, MD, Dimitrios Karakasis, MD, Maria Bouzani, MD, Chara Giatra, MD, Zois Mellios, MD, Georgia Tounta, MD, Tatiana Tzenou, MD, Dimitra Oikonomopoulou, MD, Eirini Grispou, Maria Katsareli, Maria-Eleni Karatza, Kimon Fountoulis, MD, Themistoklis Karmiris, MD, Stavros Gigantes, MD, Ioannis Baltadakis, MD

Blood (2019) 134 (Supplement_1): 4511.

https://doi.org/10.1182/blood-2019-131127

Published: 2019

Journal Articles

Study of MGUS-Series: Disease Evolution, Coexistant Disorders and Other Clinical Observations

Dimitrios Maltezas, MD, Nikolaou Eftychia, MD, Paraskevi Papaioannou, MD, Aikaterini Bitsani, MD, Tatiana Tzenou, MD, Maria Dimou, MD, Theodoros Iliakis, MD, Sotiria Kotsanti, MD, Panagiota Petsa, MD, Panayiotis Panayiotidis, Marie-Christine Kyrtsonis, MD

Blood (2015) 126 (23): 5323.

https://doi.org/10.1182/blood.V126.23.5323.5323

Published: 2015

Journal Articles

CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference

Aliki Xochelli, Panagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Eva Minga, Eugen Tausch, MD, Xiao J. Yan, Tait D. Shanafelt, MD, Karla Plevova, PhD, Myriam Boudjogra, Davide Rossi, MD PhD, Zadie Davis, Alba Navarro, Yorick Sandberg, Fie Juhl Vojdeman, Lydia Scarfo, Niki Stavroyianni, Andrey B. Sudarikov, PhD, Silvio Veronese, Tatiana Tzenou, MD, Teodora Karan-Djurasevic, Mark Catherwood, PhD, Dirk Kienle, Maria Chatzouli, Monica Facco, MS, Jasmin Bahlo, Lone Bredo Pedersen, Larry Mansouri, Karin E Smedby, MD PhD, Charles C Chu, Véronique Giudicelli, Marie-Paule Lefranc, Panagiotis Panagiotidis, Gunnar Juliusson, Achilles Anagnostopoulos, Darko Antic, Livio Trentin, Marco Montillo, Carsten Niemann, Hartmut Döhner, MD, Anton W. Langerak, Nikos Darzentas, Sarka Pospisilova, Michael Hallek, MD, Elias Campo, Nicholas Chiorazzi, MD, David Oscier, Gianluca Gaidano, MD PhD, Chrysoula Belessi, Diane F. Jelinek, Stephan Stilgenbauer, MD, Frederic Davi, Richard Rosenquist, Paolo Ghia, Kostas Stamatopoulos

Blood (2015) 126 (23): 5263.

https://doi.org/10.1182/blood.V126.23.5263.5263

Published: 2015

Journal Articles

Clonotypic Analysis Of Immunoglobulin Heavy Chain (IgH) Sequences In Patients With Waldenström’s Macroglobulinemia. Correlation With MYD88 L265P Somatic Mutation Status, Clinical Features and Outcome

Loizos Petrikkos, MD, Marie-Christine Kyrtsonis, MD, Maria Roumelioti, Anna Efthymiou, MD, Tatiana Tzenou, MD, George Georgiou, MD, Dimitrios Maltezas, MD, Panayiotis Panayiotidis, MD

Blood (2013) 122 (21): 1890.

https://doi.org/10.1182/blood.V122.21.1890.1890

Published: 2013

Journal Articles

Evaluation Of Immunoglobulin Variations (Clonal Changes) In Symptomatic Multiple Myeloma (MM) Patients’ Course

Eftychia Nikolaou, Panayiotis Panayiotidis, MD, Katerina Sarris, Dimitrios Maltezas, MD, Efstathios Koulieris, Theodoros Iliakis, Nora Vyniou, Ioanna Vardounioti, Vassiliki Karali, Ilias Pessach, Anna Efthymiou, MD, Vassiliki Bartzis, Tatiana Tzenou, MD, Maria Dimou, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Panagiotis Tsaftaridis, Nikolitsa Kafasi, Marie-Christine Kyrtsonis, MD

Blood (2013) 122 (21): 3173.

https://doi.org/10.1182/blood.V122.21.3173.3173

Published: 2013

Journal Articles

The Presence Of Spine Bone Plasmacytomas At The Time Of Multiple Myeloma (MM) Diagnosis Confers Poor Prognosis

Marie-Christine Kyrtsonis, MD, Eftychia Nikolaou, Dimitrios Maltezas, MD, Katerina Sarris, Efstathios Koulieris, Theodoros Iliakis, Nora Vyniou, Ioanna Vardounioti, Vassiliki Karali, Ilias Pessach, Vassiliki Bartzis, Tatiana Tzenou, MD, Maria Dimou, Theodoros P. Vassilakopoulos, Maria K. Angelopoulou, Panagiotis Tsaftaridis, Irene Katodritou, Panayiotis Panayiotidis, MD

Blood (2013) 122 (21): 5366.

https://doi.org/10.1182/blood.V122.21.5366.5366

Published: 2013

Journal Articles

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Blood (2007) 110 (11): 1490.

https://doi.org/10.1182/blood.V110.11.1490.1490

Published: 2007

Journal Articles

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Nicoletta Kafasi, MD, Sotirios Sachanas, MD, Tatiana Tzenou, MD, Argiroula Papadogiannis, MD, Zacharoula Galanis, MD, Christina Kalpadakis, MD, Maria Dimou, MD, Elias Kyriakou, MD, Maria K. Angelopoulou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2006) 108 (11): 3522.

https://doi.org/10.1182/blood.V108.11.3522.3522

Published: 2006

Journal Articles

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Argyro Papadogiannis, MD, Tatiana Tzenou, MD, Christina Kalpadakis, MD, Antoine Antoniadis, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Stella I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Ellen Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 3404.

https://doi.org/10.1182/blood.V106.11.3404.3404

Published: 2005

Journal Articles

Retrospective Analysis of 41 Consecutive Patients with Non Gastrointestinal (GI) Extranodal Marginal Zone B-Cell Lymphoma (EMZL): Correlation of Clinical Characteristics and Outcome with Disease Localization.

Christina Kalpadakis, MD, Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Maria N. Dimopoulou, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Maria K. Angelopoulou, MD, Fotios Mitropoulos, MD, Penelope Korkolopoulou, MD, Gerassimos A. Pangalis, MD.

Blood (2005) 106 (11): 4785.

https://doi.org/10.1182/blood.V106.11.4785.4785

Published: 2005

Journal Articles

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Argyro Papadogiannis, MD, Marie-Cristine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Tatiana Tzenou, MD, Antonios G. Antoniadis, MD, Christina Kalpadakis, MD, Sotirios Sachanas, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia M. Dimitriadou, MD, Maria K. Angelopoulou, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Gerassimos Pangalis, MD

Blood (2005) 106 (11): 5074.

https://doi.org/10.1182/blood.V106.11.5074.5074

Published: 2005

Journal Articles

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Marie-Christine Kyrtsonis, MD, Sotirios Sachanas, MD, Theodoros P. Vassilakopoulos, MD, Nikoletta Kafassi, MD, Tatiana Tzenou, MD, Argyro Papadogiannis, MD, Christina Kalpadakis, MD, Antonios G. Antoniadis, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Marina P. Siakantaris, MD, Evangelia M. Dimitriadou, MD, Styliani I. Kokoris, MD, Eleni Plata, MD, Panagiotis Tsaftaridis, MD, Panayiotis Panayiotidis, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 5193.

https://doi.org/10.1182/blood.V106.11.5193.5193

Published: 2005

Journal Articles

Lymhoma of the Oral Cavity. A Rare Entity with Favorable Prognosis. Ten-Year Experience of a Single Hematology Unit.

Marina P. Siakantaris, MD, Tatiana Tzenou, MD, Theodoros P. Vassilakopoulos, MD, Marie-Christine Kyrtsonis, MD, Maria K. Angelopoulou, MD, Maria N. Dimopoulou, MD, Styliani I. Kokoris, MD, Evangelia N. Dimitriadou, MD, Penelope Korkolopoulou, MD, Efstratios Patsouris, MD, Panayiotis Tsaftaridis, MD, Eleni Variamis, MD, George Laskaris, MD, Gerassimos A. Pangalis, MD

Blood (2004) 104 (11): 4595.

https://doi.org/10.1182/blood.V104.11.4595.4595

Published: 2004

Journal Articles

Interferon Alpha-2B (IFN-a) Is an Effective Agent for the Treatment of Primary Cutaneous T- and B-Cell Lymphoma.

Marina P. Siakantaris, MD, Marie-Christine Kyrtsonis, MD, Tatiana Tzenou, MD, Evangelia M. Dimitriadou, MD, Maria N. Dimopoulou, MD, Maria K. Angelopoulou, MD, Styliani I. Kokoris, MD, Theodoros P. Vassilakopoulos, MD, Penelope Korkolopoulou, MD, Antonia Giannakakis, MD, Eleni Plata, MD, Eustratios Patsouris, MD, Andreas Katsambas, MD, Gerassimos A. Pangalis, MD

Blood (2004) 104 (11): 2643.

https://doi.org/10.1182/blood.V104.11.2643.2643

Published: 2004

Journal Articles

Serum Soluble Syndecan-1 Levels Correlate with Erythropoietin and Inversely with Hemoglobin Levels in Untreated Anaemic Myeloma Patients: Possible Role of Syndecan-1 in the Mechanisms of Chronic Anaemia.

Marie-Christine Kyrtsonis, MD, Theodoros P. Vassilakopoulos, MD, Argyro Papadogiannis, MD, Tatiana Tzenou, MD, Maria N. Dimopoulou, MD, Marina P. Siakantaris, MD, Styliani I. Kokoris, MD, Evangelia Dimitriadou, MD, Maria K. Angelopoulou, MD, Christine Kalpadaki, MD, Gerassimos A. Pangalis, MD

Blood (2004) 104 (11): 4882.

https://doi.org/10.1182/blood.V104.11.4882.4882

Published: 2004

NARROW

Increased Incidence of Viral Reactivation after T Cell Replete Haploidentical Stem Cell Transplantation in Association with Delayed Immune Reconstitution

Study of MGUS-Series: Disease Evolution, Coexistant Disorders and Other Clinical Observations

CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference

Clonotypic Analysis Of Immunoglobulin Heavy Chain (IgH) Sequences In Patients With Waldenström’s Macroglobulinemia. Correlation With MYD88 L265P Somatic Mutation Status, Clinical Features and Outcome

Evaluation Of Immunoglobulin Variations (Clonal Changes) In Symptomatic Multiple Myeloma (MM) Patients’ Course

The Presence Of Spine Bone Plasmacytomas At The Time Of Multiple Myeloma (MM) Diagnosis Confers Poor Prognosis

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Serum Free Light Chain Ratio (FLCR) at Diagnosis Constitute a Powerful Prognostic Factor of Survival in Multiple Myeloma (MM).

Serum Soluble Syndecan-1 Levels at Diagnosis Constitute an Independent Prognostic Factor of Survival in Myeloma That May Further Differentiate Patients within the ISS Stages.

Retrospective Analysis of 41 Consecutive Patients with Non Gastrointestinal (GI) Extranodal Marginal Zone B-Cell Lymphoma (EMZL): Correlation of Clinical Characteristics and Outcome with Disease Localization.

Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.

Bortezomib in Patients with Relapsed-Refractory Multiple Myeloma (MM). Clinical Observations.

Lymhoma of the Oral Cavity. A Rare Entity with Favorable Prognosis. Ten-Year Experience of a Single Hematology Unit.

Interferon Alpha-2B (IFN-a) Is an Effective Agent for the Treatment of Primary Cutaneous T- and B-Cell Lymphoma.

Serum Soluble Syndecan-1 Levels Correlate with Erythropoietin and Inversely with Hemoglobin Levels in Untreated Anaemic Myeloma Patients: Possible Role of Syndecan-1 in the Mechanisms of Chronic Anaemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only